GB0408524A
GB0408524D0
(en)
|
2004-04-16 |
2004-04-16 |
Use
|
EP04743516A
EP1660095B1
(en)
|
2003-07-25 |
2004-07-23 |
Tricyclic parp inhibitors
|
CA2533332A
CA2533332C
(en)
|
2003-07-25 |
2004-07-23 |
Therapeutic compounds
|
US10/898,653
US7351701B2
(en)
|
2003-07-25 |
2004-07-23 |
Therapeutic compounds
|
JP2006521648A
JP5466814B2
(en)
|
2003-07-25 |
2004-07-23 |
Therapeutic compounds
|
PT04743516T
PT1660095E
(en)
|
2003-07-25 |
2004-07-23 |
Tricyclic parp inhibitors
|
AT04743516T
ATE454893T1
(en)
|
2003-07-25 |
2004-07-23 |
TRICYCLIC PARP INHIBITORS
|
SI200431370T
SI1660095T1
(en)
|
2003-07-25 |
2004-07-23 |
Tricyclic parp inhibitors
|
KR1020067001725A
KR101138471B1
(en)
|
2003-07-25 |
2004-07-23 |
Tricyclic parp inhibitors
|
DE602004025123T
DE602004025123D1
(en)
|
2003-07-25 |
2004-07-23 |
Tricyclische parp-hemmer
|
RU2006105652/04A
RU2404183C2
(en)
|
2003-07-25 |
2004-07-23 |
Tricyclic parp inhibitors
|
AU2004261462A
AU2004261462B2
(en)
|
2003-07-25 |
2004-07-23 |
Tricyclic PARP inhibitors
|
CN2004800273183A
CN1856313B
(en)
|
2003-07-25 |
2004-07-23 |
Therapeutic compounds
|
US10/565,308
US7531530B2
(en)
|
2003-07-25 |
2004-07-23 |
Therapeutic compounds
|
PL04743516T
PL1660095T3
(en)
|
2003-07-25 |
2004-07-23 |
Tricyclic parp inhibitors
|
DK04743516.9T
DK1660095T3
(en)
|
2003-07-25 |
2004-07-23 |
Tricyclic PARP Inhibitors
|
ES04743516T
ES2339663T3
(en)
|
2003-07-25 |
2004-07-23 |
TRICYCLE PARP INHIBITORS.
|
MXPA06000993A
MXPA06000993A
(en)
|
2003-07-25 |
2004-07-23 |
Therapeutic compounds.
|
NZ544989A
NZ544989A
(en)
|
2003-07-25 |
2004-07-23 |
Tricyclic PARP inhibitors
|
BRPI0412899-0A
BRPI0412899B1
(en)
|
2003-07-25 |
2004-07-23 |
USE OF A COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT FOR THE MANUFACTURE OF A CYTOTOXIC DRUG FOR THE TREATMENT OF OVARY CANCER, BREAST CANCER, PROSTATE CANCER OR PANCREATIC CANCER
|
PCT/GB2004/003183
WO2005012305A2
(en)
|
2003-07-25 |
2004-07-23 |
Tricyclic parp inhibitors
|
IL173336A
IL173336A
(en)
|
2003-07-25 |
2006-01-24 |
Pericondensed derivatives of ɛ-lactam with indole and benzimidazole for treating cancer caused by a genetic defect in a gene
|
ZA2006/00679A
ZA200600679B
(en)
|
2003-07-25 |
2006-01-24 |
Therapeutic compounds
|
NO20060928A
NO334610B1
(en)
|
2003-07-25 |
2006-02-24 |
Therapeutic Compounds and the Use of a Therapeutically Effective Amount of Compounds for the Preparation of a Cytotoxic Drug for the Treatment of Cancer
|
HK06106961.6A
HK1084602A1
(en)
|
2003-07-25 |
2006-06-19 |
Tricyclic parp inhibitors
|
CY20101100309T
CY1110335T1
(en)
|
2003-07-25 |
2010-03-31 |
Tricyclic Suspensions PARP
|
JP2011260401A
JP5580280B2
(en)
|
2003-07-25 |
2011-11-29 |
Therapeutic compounds
|